|
1
|
Williams R, Airey M, Baxter H, Forrester
J, Kennedy-Martin T and Girach A: Epidemiology of diabetic
retinopathy and macular oedema: a systematic review. Eye (Lond).
18:963–983. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ehrlich R, Harris A, Ciulla TA, Kheradiya
N, Winston DM and Wirostko B: Diabetic macular oedema: physical,
physiological and molecular factors contribute to this pathological
process. Acta Ophthalmol. 88:279–291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stewart MW: Corticosteroid use for
diabetic macular edema: old fad or new trend? Curr Diab Rep.
12:364–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu L, Wu X, Geng J, Yuan Z and Chen L:
IVTA as adjunctive treatment to PRP and MPC for PDR and macular
edema: a meta-analysis. PLoS One. 7:e446832012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson CA, Berkowitz BA, Sato Y, Ando N,
Handa JT and de Juan E Jr: Treatment with intravitreal steroid
reduces blood-retinal barrier breakdown due to retinal
photocoagulation. Arch Ophthalmol. 110:1155–1159. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Felinski EA, Cox AE, Phillips BE and
Antonetti DA: Glucocorticoids induce transactivation of tight
junction genes occludin and claudin-5 in retinal endothelial cells
via a novel cis-element. Exp Eye Res. 86:867–878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jonas JB, Kreissig I and Degenring R:
Intraocular pressure after intravitreal injection of triamcinolone
acetonide. Br J Ophthalmol. 87:24–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jonas JB, Degenring R, Vossmerbauemer U
and Kamppeter B: Frequency of cataract surgery after intravitreal
injection of high-dosage triamcinolone acetonide. Eur J Ophthalmol.
15:462–464. 2005.PubMed/NCBI
|
|
9
|
Fu F, Hou Y, Jiang W, Wang R and Liu K:
Escin: inhibiting inflammation and promoting gastrointestinal
transit to attenuate formation of postoperative adhesions. World J
Surg. 29:1614–1620. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Fu F, Zhang X, Zhu M, Wang T and
Fan H: Escin attenuates cognitive deficits and hippocampal injury
after transient global cerebral ischemia in mice via regulating
certain inflammatory genes. Neurochem Int. 57:119–127. 2010.
View Article : Google Scholar
|
|
11
|
Wang T, Fu F, Zhang L, Han B, Zhu M and
Zhang X: Effects of escin on acute inflammation and the immune
system in mice. Pharmacol Rep. 61:697–704. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Wang H, Fan H, et al: The potent
anti-inflammatory agent escin does not increase corticosterone
secretion and immune cell apoptosis in mice. Fitoterapia.
82:861–867. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xin W, Zhang L, Sun F, et al: Escin exerts
synergistic anti-inflammatory effects with low doses of
glucocorticoids in vivo and in vitro. Phytomedicine. 18:272–277.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong YY, Yu SQ, Wang H, et al: Clinical
therapy of retinal vein occlusion with aescuven forte. Chin J New
Drugs Clin Rem. 24:965–967. 2005.(In Chinese).
|
|
15
|
Wang WJ, Gong YY, Wang H, et al: Aescuven
forte in treating central serous chorioretinopathy. Chin J New
Drugs Clin Rem. 24:961–964. 2005.(In Chinese).
|
|
16
|
Yuan Y and Wu L: Clinical observation of
the central serous chorioretinopathy treated by aescinate sodium
tablets combined with argon laser. Guiding Journal of TCM and
Pharmacology. 15:58–59. 2009.(In Chinese).
|
|
17
|
Berenbaum MC: What is synergy? Pharmacol
Rev. 41:93–141. 1989.PubMed/NCBI
|
|
18
|
Tsujikawa A, Ogura Y, Hiroshiba N, et al:
Retinal ischemia-reperfusion injury attenuated by blocking of
adhesion molecules of vascular endothelium. Invest Ophthalmol Vis
Sci. 40:1183–1190. 1999.PubMed/NCBI
|
|
19
|
Yilmaz T, Celebi S and Kükner AS: The
protective effects of melatonin, vitamin E and octreotide on
retinal edema during ischemia-reperfusion in the guinea pig retina.
Eur J Ophthalmol. 12:443–449. 2002.PubMed/NCBI
|
|
20
|
Furuse M, Hirase T, Itoh M, et al:
Occludin: a novel integral membrane protein localizing at tight
junctions. J Cell Biol. 123:1777–1788. 1993. View Article : Google Scholar
|
|
21
|
Xu HZ and Le YZ: Significance of outer
blood-retina barrier breakdown in diabetes and ischemia. Invest
Ophthalmol Vis Sci. 52:2160–2164. 2011. View Article : Google Scholar : PubMed/NCBI
|
